IPO registrations (S-1, F-1) · Registrants

Inhibikase Therapeutics, Inc.

SEC CIK

1750149 · filings on EDGAR ↗

Registration

Form S-1, first filed 2020-07-23, last 2024-06-18; 5 initial registrations, 9 amendments

Outcome

Final prospectus filed 2020-12-28; declared effective 2020-12-22; withdrawal requested 2024-05-15

Industry (SIC)

Biological Products, (No Diagnostic Substances) 2836

Incorporated in

DE

Business address

1000 N. WEST STREET, SUITE 1200, Wilmington, DE 19801

EIN

26-3407249

Ticker

IKT (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

Inhibikase Therapeutics, Inc. on the corporate pages

On this site

• Business registration: INHIBIKASE THERAPEUTICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
• Business registration: Inhibikase Therapeutics, Inc. Fuzzy (name and state)
• Business registration: INHIBIKASE THERAPEUTICS, INC. Fuzzy (name and state)
• Business registration: INHIBIKASE THERAPEUTICS, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: INHIBIKASE THERAPEUTICS, INC. EXACT (EIN (EXACT))
• Form D issuer: Inhibikase Therapeutics, Inc. EXACT (CIK (EXACT))
• SEC filer: Inhibikase Therapeutics, Inc. EXACT (CIK (EXACT))

Filings 27

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.